Contemporary analysis of the influence of acute kidney injury after reduced intensity conditioning haematopoietic cell transplantation on long-term survival

被引:29
作者
Lopes, J. A. [1 ]
Goncalves, S. [1 ]
Jorge, S. [1 ]
Raimundo, M. [1 ]
Resende, L. [1 ]
Lourenco, F. [2 ]
Lacerda, J. F. [2 ]
Martins, C. [2 ]
do Carmo, J. A. [2 ]
Lacerda, J. M. F. [2 ]
Prata, M. M. [1 ]
机构
[1] Hosp Santa Maria, Dept Nephrol & Renal Transplantat, P-1649035 Lisbon, Portugal
[2] Hosp Santa Maria, Dept Haematol, P-1649035 Lisbon, Portugal
关键词
acute kidney injury; haematopoietic cell transplantation; long-term survival; reduced intensity conditioning;
D O I
10.1038/bmt.2008.207
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We evaluated retrospectively the incidence of acute kidney injury (AKI), defined by risk, injury, failure, loss and end-stage kidney disease (RIFLE) and its influence on long-term survival, in 82 patients aged 18-60 years who underwent a reduced intensity conditioning (RIC) haematopoietic cell transplantation (HCT). Patients (53.6%) developed AKI after HCT: 25% were on risk, 45.5% on injury and 29.5% on failure. In all, 64 patients survived after 100 days of post transplant and were available for long-term survival analysis. At follow-up, 43.7% of patients died. A 5-year overall survival of AKI patients was 41.6% as compared with 67.1% for those who did not develop AKI (P = 0.028), and decreased according to AKI severity (risk, 55.6%; injury plus failure, 33.3%; P = 0.045). After adjusting for age, history of cardiovascular disease, high-risk disease and chronic GVHD, AKI predicted 5-year overall mortality (AKI: adjusted hazards ratio (AHR), 2.36, 95% CI: 1.03-5.37; P = 0.041). Moreover, moderate and severe AKI (injury plus failure) was also associated with an increased 5-year overall mortality (injury plus failure: AHR, 1.64, 95% CI: 1.06-2.54; P = 0.024). According to RIFLE, 53.6% of patients had AKI after RIC HCT. Such patients have poor long-term survival, particularly in moderate or severe AKI.
引用
收藏
页码:619 / 626
页数:8
相关论文
共 38 条
[1]   One-year mortality in critically ill patients by severity of kidney dysfunction: A population-based assessment [J].
Bagshaw, Sean M. ;
Mortis, Garth ;
Doig, Christopher J. ;
Godinez-Luna, Tomas ;
Fick, Gordon H. ;
Laupland, Kevin B. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 48 (03) :402-409
[2]   Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies:: Experience from the European Group for Blood and Marrow Transplantation [J].
Belkacemi, Yazid ;
Labopin, Myriam ;
Hennequin, Christophe ;
Hoffstetter, Sylvette ;
Mungai, Raffaello ;
Wygoda, Marc ;
Lundell, Marie ;
Finke, Jurgen ;
Aktinson, Chris ;
Lorchel, Frederic ;
Durdux, Catherine ;
Basara, Nadezda .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (02) :544-551
[3]   Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group [J].
Bellomo, R ;
Ronco, C ;
Kellum, JA ;
Mehta, RL ;
Palevsky, P .
CRITICAL CARE, 2004, 8 (04) :R204-R212
[4]   Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors [J].
Blaise, D ;
Bay, JO ;
Faucher, C ;
Michallet, M ;
Boiron, JM ;
Choufi, B ;
Cahn, JY ;
Gratecos, N ;
Sotto, JJ ;
François, S ;
Fleury, J ;
Mohty, M ;
Chabannon, C ;
Bilger, K ;
Gravis, G ;
Viret, F ;
Braud, AC ;
Bardou, VJ ;
Maraninchi, D ;
Viens, P .
BLOOD, 2004, 103 (02) :435-441
[5]   Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus [J].
Burt, RK ;
Traynor, A ;
Statkute, L ;
Barr, WG ;
Rosa, R ;
Schroeder, J ;
Verda, L ;
Krosnjar, N ;
Quigley, K ;
Yaung, K ;
Villa, M ;
Takahashi, M ;
Jovanovic, B ;
Oyama, Y .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (05) :527-535
[6]   Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation [J].
Childs, R ;
Chernoff, A ;
Contentin, N ;
Bahceci, E ;
Schrump, D ;
Leitman, S ;
Read, EJ ;
Tisdale, J ;
Dunbar, C ;
Linehan, WM ;
Young, NS ;
Barrett, AJ ;
Clave, E ;
Epperson, D ;
Mayo, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (11) :750-758
[7]   Advances in allogeneic stem cell transplantation: Directing graft-versus-leukemia at solid tumors [J].
Childs, R ;
Srinivasan, R .
CANCER JOURNAL, 2002, 8 (01) :2-11
[8]   Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors [J].
Diaconescu, R ;
Flowers, CR ;
Storer, B ;
Sorror, ML ;
Maris, MB ;
Maloney, DG ;
Sandmaier, BM ;
Storb, R .
BLOOD, 2004, 104 (05) :1550-1558
[9]   Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation [J].
Giralt, S ;
Thall, PF ;
Khouri, I ;
Wang, XM ;
Braunschweig, I ;
Ippolitti, C ;
Claxton, D ;
Donato, M ;
Bruton, J ;
Cohen, A ;
Davis, M ;
Andersson, BS ;
Anderlini, P ;
Gajewski, J ;
Kornblau, S ;
Andreeff, M ;
Przepiorka, D ;
Ueno, NT ;
Molldrem, J ;
Champlin, R .
BLOOD, 2001, 97 (03) :631-637
[10]   Older patients with high-risk fungal infections can be successfully allografted using non-myeloablative conditioning in combination with intensified supportive care regimens [J].
Hermann, S ;
Klein, SA ;
Jacobi, V ;
Thalhammer, A ;
Bialleck, H ;
Duchscherer, M ;
Wassmann, E ;
Hoelzer, D ;
Martin, H .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) :446-454